Skip Navigation


Brain Advance Access originally published online on April 27, 2005
Brain 2005 128(8):1778-1789; doi:10.1093/brain/awh531
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
128/8/1778    most recent
awh531v3
awh531v2
awh531v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (23)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Liu, Y.
Right arrow Articles by Fassbender, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, Y.
Right arrow Articles by Fassbender, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2005). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide

Yang Liu1, Silke Walter1,*, Massimiliano Stagi3,4,*, Dmitry Cherny7,8, Maryse Letiembre1, Walter Schulz-Schaeffer2, Holger Heine5, Botond Penke9, Harald Neumann3,4 and Klaus Fassbender6

1 Departments of Neurology and 2 Neuropathology, University of Göttingen, 3 European Neuroscience Institute and 4 Institute of Multiple Sclerosis Research, University of Göttingen and Hertie-Foundation, Göttingen, 5 Borstel Research Centre, Centre for Medicine and Biosciences, Borstel, 6 Department of Neurology, University Hospital, Homburg, Saar, Germany, 7 Department of Biochemistry, University of Leicester, Leicester, UK, 8 Institute of Molecular Genetics, Russian Academy of Sciences, Moscow, Russia and 9 Department of Medical Chemistry, Albert Szent Gyorgyi Medical University, Szeged, Hungary

Correspondence to: Yang Liu or Klaus Fassbender, Department of Neurology, University of Göttingen, Robert Koch Str. 40, 37075 Göttingen, Germany E-mail: alexliu{at}med.uni-goettingen.de; klaus.fassbender{at}med.uni-goettingen.de

The amyloid ß peptide 42 (Aß42) plays a key role in neurotoxicity in Alzheimer's disease. Mononuclear phagocytes, i.e. microglia, have the potential to clear Aß by phagocytosis. Recently, the lipopolysaccharide (LPS) receptor CD14 was shown to mediate phagocytosis of bacterial components and furthermore to contribute to neuroinflammation in Alzheimer's disease. Here, we investigated whether this key innate immunity receptor can interact with Aß42 and mediate phagocytosis of this peptide. Using flow cytometry, confocal microscopy and two-photon fluorescence lifetime imaging (FLIM) combined with fluorescence resonance energy transfer (FRET), we demonstrated a direct molecular interaction in the range of a few nanometers between Aß42 and CD14 in human CD14-transfected Chinese hamster ovary cells. Investigations using cells that were genetically deficient for this receptor showed that in <30 minutes exogenous 42 added to cultured primary microglial cells was phagocytosed into the cytoplasmic compartment in a CD14-dependent manner. This phagocytosis occurred at Aß42 concentration ranges that were considerably lower than the threshold to activate a cellular inflammatory reaction. In contrast, there was no association of CD14 to microglial internalization of microbeads. In complementary clinical experiments, we detected a pronounced CD14 immunoreactivity on parenchymal microglia spatially correlated to characteristic Alzheimer's disease lesion sites in brain sections of Alzheimer's disease patients but not in brain sections of control subjects. By showing a close interaction between CD14 and Aß42, demonstrating a direct role of CD14 in Aß42 phagocytosis, and detecting CD14-specific staining in brains of Alzheimer's disease patients, our results indicate a role of the LPS receptor in the pathophysiology of Alzheimer's disease, which could be of therapeutic relevance.

Key Words: Alzheimer's disease; amyloid ß protein; CD14; microglia; phagocytosis

Abbreviations: Aß = amyloid ß peptide; CHO = Chinese hamster ovary; fAß42 = fibrillar amyloid ß peptide 42; FLIM = fluorescence lifetime imaging; FRET = fluorescence resonance energy transfer; iNOS = inducible nitric oxide synthase; LPS = lipopolysaccharide; mFI = mean fluorescence value; SEM = standard error of the mean; TCSPC = time-correlated single photon counting; TNF-{alpha} = tumour necrosis factor-{alpha}

.


* These authors contributed equally to this work.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Neurosci.Home page
K. L. Richard, M. Filali, P. Prefontaine, and S. Rivest
Toll-Like Receptor 2 Acts as a Natural Innate Immune Receptor to Clear Amyloid {beta}1-42 and Delay the Cognitive Decline in a Mouse Model of Alzheimer's Disease
J. Neurosci., May 28, 2008; 28(22): 5784 - 5793.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
L. Calderon-Garciduenas, A. C. Solt, C. Henriquez-Roldan, R. Torres-Jardon, B. Nuse, L. Herritt, R. Villarreal-Calderon, N. Osnaya, I. Stone, R. Garcia, et al.
Long-term Air Pollution Exposure Is Associated with Neuroinflammation, an Altered Innate Immune Response, Disruption of the Blood-Brain Barrier, Ultrafine Particulate Deposition, and Accumulation of Amyloid {beta}-42 and {alpha}-Synuclein in Children and Young Adults
Toxicol Pathol, February 1, 2008; 36(2): 289 - 310.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Liu, W. Hao, M. Letiembre, S. Walter, M. Kulanga, H. Neumann, and K. Fassbender
Suppression of Microglial Inflammatory Activity by Myelin Phagocytosis: Role of p47-PHOX-Mediated Generation of Reactive Oxygen Species
J. Neurosci., December 13, 2006; 26(50): 12904 - 12913.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. A. Babcock, M. Wirenfeldt, T. Holm, H. H. Nielsen, L. Dissing-Olesen, H. Toft-Hansen, J. M. Millward, R. Landmann, S. Rivest, B. Finsen, et al.
Toll-Like Receptor 2 Signaling in Response to Brain Injury: An Innate Bridge to Neuroinflammation
J. Neurosci., December 6, 2006; 26(49): 12826 - 12837.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
S. POZZI, V. BENEDUSI, A. MAGGI, and E. VEGETO
Estrogen Action in Neuroprotection and Brain Inflammation
Ann. N.Y. Acad. Sci., November 1, 2006; 1089(1): 302 - 323.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
K. Tahara, H.-D. Kim, J.-J. Jin, J. A. Maxwell, L. Li, and K.-i. Fukuchi
Role of toll-like receptor signalling in A{beta} uptake and clearance
Brain, November 1, 2006; 129(11): 3006 - 3019.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
D. G. Walker, J. Link, L.-F. Lue, J. E. Dalsing-Hernandez, and B. E. Boyes
Gene expression changes by amyloid {beta} peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes
J. Leukoc. Biol., March 1, 2006; 79(3): 596 - 610.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.